Date: 2015-11-03
Type of information: IPO
Company: Myokardia (USA - CA)
Investors:
Amount: $55.7 million
Funding type: IPO
Planned used:
Others: * On November 3, 2015, MyoKardia announced the closing of its initial public offering of 6,253,125 shares of common stock at a public offering price of $10.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 815,625 shares of common stock. All of the shares sold in the offering were offered by MyoKardia. The shares began trading on The NASDAQ Global Select Market under the ticker symbol "MYOK" on October 29, 2015. The Company estimates net proceeds from the offering to be approximately $55.7 million, after deducting underwriting discounts and commissions and estimated offering expenses. Credit Suisse Securities (USA) LLC and Cowen and Company, LLC acted as lead book-running managers. Wells Fargo Securities acted as book-running manager. Wedbush PacGrow acted as co-manager.
Therapeutic area: Cardiovascular diseases
